Pathway-specific inhibition of primaquine metabolism by chloroquine/quinine.
Pius S FasinuBabu L TekwaniBharathi AvulaNarayan D ChaurasiyaN P Dhammika NanayakkaraYan-Hong WangIkhlas A KhanLarry A WalkerPublished in: Malaria journal (2016)
The metabolite-specific interactions in the current studies seem at variance with earlier reports of the dependence of PQ on CYP2D6 metabolism, and enhanced PQ anti-malarial activity/reduced toxicity in the presence of CQ/QN. These results suggest a complex picture in which CQ/QN may shift metabolite pathway balances towards a profile that retains efficacy, while reducing the formation or availability of toxic metabolites to erythrocytes. Alternatively, these drugs may alter transport or distribution of PQ metabolites in a fashion that reduces toxicity while maintaining efficacy against the parasite.